SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Year-over-year total asset growth rate
5Y CAGR
-19.0%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 51.96% |
| Q3 2025 | 59.59% |
| Q2 2025 | -7.58% |
| Q1 2025 | 79.89% |
| Q4 2024 | -26.69% |
| Q3 2024 | 75.31% |
| Q2 2024 | -38.12% |
| Q1 2024 | 292.89% |
| Q4 2023 | -23.09% |
| Q3 2023 | -56.45% |
| Q2 2023 | -36.21% |
| Q1 2023 | 38.97% |
| Q4 2022 | -19.45% |
| Q3 2022 | -19.28% |
| Q2 2022 | 50.28% |
| Q1 2022 | -18.89% |
| Q4 2021 | -30.37% |
| Q3 2021 | -13.00% |
| Q2 2021 | 7.51% |
| Q1 2021 | -11.89% |
| Q4 2020 | 148.79% |
| Q3 2020 | 27.53% |
| Q2 2020 | -14.75% |
| Q1 2020 | 2.51% |
| Q4 2019 | -22.69% |
| Q3 2019 | -14.18% |
| Q2 2019 | 67.71% |
| Q1 2019 | -11.75% |
| Q4 2018 | -56.03% |
| Q3 2018 | 20.32% |
| Q2 2018 | -4.52% |
| Q1 2018 | -0.12% |
| Q4 2017 | -32.40% |
| Q3 2017 | -18.10% |
| Q2 2017 | -13.90% |
| Q1 2017 | 6.87% |
| Q4 2016 | -9.66% |
| Q3 2016 | -1.26% |
| Q2 2016 | 11.17% |
| Q1 2016 | -19.21% |